drugset / Trial / NCT02084576

Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification

NCT02084576

Phase 4 Completed 40 enrolled Hospital Oftalmologico de Brasilia
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the anti-inflammatory efficacy of ketorolac of tromethamine 0.4% and nepafenac 0.1% eye drops for prophylaxis of cystoid macular edema (CME) after small-incision cataract extraction.

Timeline

Start
2013-08
Primary completion
2013-08
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 0.4 % Topical
Subject Nepafenac Other / unclassified 0.1 % Topical